-
-
METHYLPHENIDATE ER (Generic for APTENSIO XR)
- QTY 30
- 36 MG
- TAB ER 24
- Near 77381
METHYLPHENIDATE (meth il FEN i date) treats attention-deficit hyperactivity disorder (ADHD). It works by improving focus and reducing impulsive behavior. It may also be used to treat narcolepsy. It works by promoting wakefulness. It belongs to a group of medications called stimulants.
Change Location
Set Price Drop Alert for:
METHYLPHENIDATE ER (Generic for APTENSIO XR)
- QTY 30
- 36 MG
- TAB ER 24
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
METHYLPHENIDATE ER (Generic for APTENSIO XR)
- QTY 30
- 36 MG
- TAB ER 24
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Change Form
Medicine Chest
METHYLPHENIDATE ER (Generic for APTENSIO XR) Lifestyle Interactions
-
Dexamethasone 0.7mg, Implant
• Interaction: Marijuana• Severity: Moderate• Notes for Consumers: The effects of marijuana may be decreased if combined with this medicine. Do not drive or operate machinery until you know how this combination will affect you. Contact your health care provider right away if you notice slurred speech, confusion, severe drowsiness, increased heart rate, or any other new or unusual side effects.• Notes for Professionals: The incidence of marijuana associated adverse effects may change following coadministration with dexamethasone. Dexamethasone is an inducer of CYP3A4, an isoenzyme partially responsible for the metabolism of marijuana's most psychoactive compound, delta-9-tetrahydrocannabinol (Delta-9-THC). When given concurrently with dexamethasone, the amount of Delta-9-THC converted to the active metabolite 11-hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC) may be increased. These changes in Delta-9-THC and 11-OH-THC plasma concentrations may result in an altered marijuana adverse event profile.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
